Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study-Reference-Cited by-同舟云学术

Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study

Published:2022-07-25 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Zeng Huiqiong¹,Liu Hanjiang²,Liu Zhi³,Zhou Xiakai⁴,Lu Xiaoping¹,Yan Zhenbo¹,Zhou Yan¹,Dai Liping¹,Chen Yashuo¹,Yang Tingting¹,Yin Zhihua¹,Ye Zhizhong¹

Affiliation:

1. Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, Guangdong, China

2. Guangzhou Yusu Biomedical Technology Co., Haizhu District, Guangzhou, China

3. Department of Pulmonary Medicine & Tuberculosis, The Third People’s Hospital of Shenzhen, Shenzhen, People’s Republic of China

4. CAS Joint Laboratory on Stem Cell and Regenerative Medicine, The Chinese University of Hong Kong, School of Biomedical Sciences, CUHK-GIBH, Shatin, Hong Kong, Special Administrative Region of China

Funder

Sanming Project of Medicine in Shenzhen

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2090176

Reference60 articles.

1. World Health Organization. WHO coronavirus disease (COVID-19) dashboard. [accessed 2021 Oct 16]. https://covid19.who.int/?gclid=EAIaIQobChMI2_CM6eDZ6gIVghh9Ch3nDQm1EAAYASAAEgLqwPD_BwE.

2. SARS-CoV-2 vaccine candidates in rapid development

3. Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis

4. Vaccines and Disease-Modifying Antirheumatic Drugs

5. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of inactivated SARS‐CoV‐2 vaccination in COVID‐19‐associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real‐world retrospective observational study;International Journal of Rheumatic Diseases;2024-05

2. Characterization and trajectories of hematological parameters prior to severe COVID-19 based on a large-scale prospective health checkup cohort in western China: a longitudinal study of 13-year follow-up;BMC Medicine;2024-03-07

3. Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases;Vaccines;2024-03-06

4. Global Perspective on the Impact of the COVID‐19 Pandemic on Rheumatology and Health Equity;Arthritis Care & Research;2023-07-20

5. Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis;Frontiers in Public Health;2022-09-20